Dr. Reddy's Laboratories Ltd.

View in App
4610.45 +58.40 ▲1.3%

02 June 2023, 04:14:25 PM
Volume: 501,913

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.drreddys.com
Market Cap 76,753.53 Cr.
Enterprise Value(EV) 76,142.33 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 270.66 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 17.03 Trailing Twelve Months Ending 2023-03
Industry PE 33.43 Trailing Twelve Months Ending 2023-03
Book Value / Share 1,398.33 Trailing Twelve Months Ending 2023-03
Price to Book Value 3.30 Calculated using Price: 4,609.05
Dividend Yield 0.87 Period Ending 2022-03
No. of Shares Subscribed 16.65 Cr. 166,527,876 Shares
FaceValue 5
About Dr. Reddy's Laboratories Ltd.
The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.

Dr. Reddy's Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Dr. Reddy's Laboratories Ltd. Performance

View details >>
1 Day
+1.28%
1 Week
+1.75%
1 Month
-6.87%
3 Month
+5.01%
6 Month
+2.22%
1 Year
+6.40%
2 Year
-13.21%
5 Year
+137.48%
10 Year
+120.38%

Dr. Reddy's Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 27.88 26.63 18.95 10.20 7.40 14.75 13.76 11.82 11.93
Return on Capital Employed (%) 25.00 22.70 19.55 9.77 8.21 13.66 11.12 15.49 14.59
Return on Assets (%) 13.47 13.67 11.05 6.14 4.23 8.86 9.20 8.21 8.08

Dr. Reddy's Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 7,865 9,853 12,570 12,262 12,572 14,024 15,599 17,642 19,212 23,286
Non Curr. Liab. 2,182 1,678 877 456 2,538 2,113 -808 -197 -508 -278
Curr. Liab. 5,790 6,821 6,347 8,420 6,894 5,897 7,214 8,104 9,766 8,572
Minority Int.
Equity & Liab. 15,838 18,353 19,794 21,138 22,004 22,034 22,005 25,548 28,470 31,580
Non Curr. Assets 5,512 6,476 8,000 11,454 11,505 10,924 9,406 10,998 10,682 11,154
Curr. Assets 10,326 11,877 11,794 9,684 10,498 11,110 12,599 14,535 17,788 20,426
Misc. Exp. not W/O
Total Assets 15,838 18,353 19,794 21,138 22,004 22,034 22,005 25,548 28,470 31,580

Dr. Reddy's Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 13,415 15,023 15,568 14,196 14,281 15,448 17,517 19,048 21,545 24,670
Other Income 196 275 295 172 155 338 621 291 485 1,092
Total Income 13,611 15,298 15,863 14,368 14,436 15,786 18,138 19,339 22,030 25,762
Total Expenditure -10,165 -11,530 -11,983 -11,724 -11,930 -12,270 -15,047 -15,178 -17,778 -18,357
PBIDT 3,446 3,769 3,880 2,644 2,506 3,516 3,091 4,161 4,252 7,404
Interest -153 -109 -83 -63 -79 -89 -98 -97 -96 -143
Depreciation -648 -760 -939 -1,027 -1,077 -1,135 -1,163 -1,229 -1,165 -1,250
Taxation -683 -563 -751 -297 -438 -386 140 -932 -879 -1,541
Exceptional Items
PAT 1,963 2,336 2,108 1,257 912 1,950 2,026 1,952 2,183 4,470
Minority Interest
Share Associate 23 35 34 37
Other Related Items
Consolidated Net Profit 1,963 2,336 2,131 1,292 947 1,950 2,026 1,952 2,183 4,507
Adjusted EPS 115 137 125 78 57 117 122 117 131 271

Dr. Reddy's Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1,378 1,970 2,524 3,263 2,144 1,803 2,870 2,984 3,570 2,811
Cash Fr. Inv. -1,446 -1,694 -2,265 -2,039 -1,840 -1,488 -773 -492 -2,266 -2,639
Cash Fr. Finan. -157 -24 -433 -1,700 -369 -444 -2,133 -2,516 -30 -242
Net Change -225 251 -174 -477 -65 -129 -35 -24 1,275 -70
Cash & Cash Eqvt 520 862 583 492 378 254 223 196 1,482 1,485

Dr. Reddy's Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 26.74 26.73 26.72 26.72 26.72 26.71 26.71 26.70 26.70
Public 61.06 61.18 61.24 61.75 62.05 62.92 63.21 62.77 62.00
Depository Receipts 12.21 12.09 12.05 11.53 11.23 10.37 10.08 10.53 11.30
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Dr. Reddy's Laboratories Ltd. Announcements

View details >>
Thu, 01 Jun 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet
Wed, 31 May 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet
Fri, 26 May 2023
Loss of Share Certificates
Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates

Dr. Reddy's Laboratories Ltd. Technical Scans

View details >>
Fri, 02 Jun 2023
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Week High Close Above Last Week High
S Closing Above Previous High for 2 Days
S Making Higher Highs for 2 Days

Dr. Reddy's Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 239,777.54 999.35 +1.2%
Divi's Laboratories Ltd. 93,340.08 3,539.90 +0.4%
Cipla Ltd. 77,917.34 966.85 +0.3%
Apollo Hospitals Enterprise Ltd. 71,422.15 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. 60,134.99 1,774.00 -0.1%
Mankind Pharma Ltd. 58,728.27 1,466.05 +4.9%
Zydus Lifesciences Ltd. 52,487.85 519.40 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.30 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 51.54 3,539.90 +0.4%
Cipla Ltd. Consolidated 2023-03 27.85 966.85 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 87.03 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.23 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 43.99 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 26.82 519.40 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.28 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7.36 3,539.90 +0.4%
Cipla Ltd. Consolidated 2023-03 3.33 966.85 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.52 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.65 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 3.00 519.40 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 0.04 966.85 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 519.40 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 519.40 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 519.40 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 966.85 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 519.40 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 966.85 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 519.40 +1.2%

Dr. Reddy's Laboratories Ltd. FAQ's

What is Dr. Reddy's Lab share price?
Can I buy Dr. Reddy's Lab shares now?
What is the Dividend Yield of Dr. Reddy's Lab?
What is the Market Cap of Dr. Reddy's Lab?
What are the key metrics to analyse Dr. Reddy's Lab?
What is the 52 Week High and Low of Dr. Reddy's Lab?
What is the trend of Dr. Reddy's Lab share price?